Antisense Oligonucleotides and RNA Interference - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 384

[254] Crooke S, Lebleu B. Antisense research and applications. Boca Raton, FL: CRC Press;
1993.
[255] Wong YF, Chung TKH, Cheung TH, Lam SK, Chang AMZ. Effects of human papil-
lomavirus type-specific antisense oligonucleotides on cervical cancer cells containing
papillomavirus type 16. Med Oncol 1994;11:149-51.
[256] Pokrovsky AG, Plyasunova OA, Blinov VM, Abramova TV, Svinarchuk FP, Vlassov VV.
Anti-HIV action of antisense and sense oligodeoxynucleotides and its derivatives. Int
Conf AIDS 1992;8:32.
[257] Yao ZQ, Zhou YX, Feng XM, Chen ZX. Specific inhibition of hepatitis b virus gene
expression by an antisense oligonucleotide in vitro . Acta Virol 1995;39:227-30.
[258] Mizuta T, Fujiwara M, Abe T, Miyano-Kurosaki N, Yokota T, Shigeta S, et al. Inhibitory
effects of an antisense oligonucleotide in an experimentally infected mouse model of
influenza a virus. Biochem Biophys Res Commun 2000;279:158-61.
[259] Vinogradov SV, Suzdaltseva Y, Alakhov VY, Kabanov AV. Inhibition of herpes simplex
virus 1 reproduction with hydrophobized antisense oligonucleotides. Biochem Biophys
Res Commun 1994;203:959-66.
[260] http:// www.sirna.com
[261] http:// patft.uspto.gov/netahtml/PTO/search-adv.htm20. Accessed December 2009.